Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05493137
Other study ID # A096376
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 1, 2022
Est. completion date October 1, 2023

Study information

Verified date August 2022
Source Cambridge University Hospitals NHS Foundation Trust
Contact Kieren Lock, Bsc
Phone 01223256726
Email kieren.lock@addenbrookes.nhs.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will investigate if parental physical activity levels, assessed by providing a physical activity questionnaire to parents of children aged 6-16 with Cystic Fibrosis (CF), is associated with their child with CF's physical activity levels. Children's activity levels will be taken from electronic records where a questionnaire is routinely given at annual reviews to analyse this. Parental activity levels will also be compared against adherence to nebulisers as a proxy for adherence to treatment, this data is again in the electronic records of patients and is collected at annual reviews.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date October 1, 2023
Est. primary completion date October 1, 2023
Accepts healthy volunteers No
Gender All
Age group 5 Years to 16 Years
Eligibility Inclusion Criteria: 1. Parents of Children aged 5-16 years. 2. Under the care of Cambridge University Hospitals CF team 3. Confirmed Cystic Fibrosis diagnosis 4. Uses an ineb as main nebulizer delivery device. 5. Parental/guardian permission (informed consent) and if appropriate, child assent. Exclusion Criteria: 1. Parents of CYP diagnosed with a CF screen positive inconclusive diagnosis (SPID). 2. If not yet doing lung function. 3. If has any other self-identified physical disability which may limit physical activity.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention will be provided
No intervention will be provided, this is an observational study

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cambridge University Hospitals NHS Foundation Trust

Outcome

Type Measure Description Time frame Safety issue
Primary GPAQ Activity questionnaire for parents Reviews the past 7 days activities.
Secondary CPAQ Physical activity Questionnaire for children aged 5-11 (From medical notes) Reviews the past 7 days activities.
Secondary YPAQ Physical activity Questionnaire for children aged 12 and over (From medical notes) Reviews the past 7 days activities.
Secondary Ineb adherence Adherence to recommended number of nebulised treatment from the i-adhere software downloaded from the ineb device. 1 year
Secondary Lung function FEV1 (z-score and %), FVC (z-score and %), FEF2575 (z-score and %) (From medical notes) Best score in the last 1 year.
See also
  Status Clinical Trial Phase
Completed NCT03637504 - Feasibility of a Mobile Medication Plan Application in CF Patient Care N/A
Active, not recruiting NCT04602468 - Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) Phase 4
Completed NCT06109675 - Nutritional Status Assessment of Pediatric Cystic Fibrosis Patients and Effect of Nutrition Education on Nutritional Status N/A
Active, not recruiting NCT04392544 - Intestinal Inflammation in CF Patients
Completed NCT04084041 - Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis N/A
Not yet recruiting NCT03292718 - Clinical Trial to Assess Influence of MyCyFAPP Use on GI Related QOL in Children With Cystic Fibrosis N/A
Enrolling by invitation NCT06188988 - Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Recruiting NCT04174664 - Comparison of Different Functional Capacity Tests in Cystic Fibrosis Patients With Acute Pulmonary Exacerbation
Completed NCT04138589 - Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function
Completed NCT03579173 - Determinants of Early Cystic Fibrosis Lung Disease
Recruiting NCT05850351 - Virtual Reality Based Tele-Exercises on Exercise Capacity in Cystic Fibrosis N/A
Completed NCT04463628 - Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
Completed NCT04835376 - Percussion Palm Cup: Safety and Usability in Infants and Children With Cystic Fibrosis N/A
Completed NCT04293926 - Heart Rate Variability in Children and Adolescents With Cystic Fibrosis N/A
Completed NCT04987567 - Effect of Antioxidant Docosahexaenoic Acid (DHA) in Cystic Fibrosis Patients N/A
Withdrawn NCT04415268 - Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis N/A
Not yet recruiting NCT06066723 - 19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
Terminated NCT03939065 - Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management N/A
Active, not recruiting NCT04613128 - The PROMISE Pediatric Study 6 to 11 Years Old
Completed NCT06242951 - Cardiopulmonary Fitness in Children With Cystic Fibrosis Compared to Healthy Children